Jens Wuerfel MD, PhD

Medical training at the Universities of Heidelberg/Germany, Luebeck/Germany, Sydney/Australia, UCL London/GB, NWU Chicago/USA 1993-2001. Clinical training in Neurology 2001-2007 at the Charité University Medicine Berlin/Germany, and in Neuroradiology/Radiology 2008-2012 at the University Luebeck/Germany. Since March 2015, CEO MIAC AG, Basel (Switzerland) and head of qbig, Department of Biomedical Engineering, University Basel.

Research activities: PhD thesis at the German Cancer Research Center Heidelberg/Germany 1996-97 in tumor immunology. Research fellowship, Raymond Way Research Group, National Institute of Neurology, Queen Square, London/GB 1999-00. Research fellowship, National Institutes of Health, NINDS, Bethesda/USA 2001-2003. Head of Neuroimmunological Imaging, Institute of Neuroimmunology, Charité University Medicine Berlin/Germany since 2001. Group leader of Experimental Neuroradiology, Institute of Neuroradiology, University Luebeck/Germany 2008-2012. Head of Experimental Neuroimaging (xni) and Trans Regional Image Analysis Laboratory (TRIAL), University Medicine Goettingen/Germany 2012-2016. Speaker of the MRI platform of the German Competence Network Multiple Sclerosis 2013-2016. Guest Scientist of the Max Delbrueck Center for Molecular Medicine, Berlin/Germany and the Berlin Ultrahigh Field Facility since 2010. Head of qbig (the Quantitative Biomedical Imaging Group), Department for Biomedical Engineering, University Basel/Switzerland since 2015.

Over 150 peer-reviewed publications have a main focus on neuro-inflammatory, neurodegenerative and quantitative MRI, ultrahigh field MRI, animal model MRI and MR elastography.